START Follow-up Study

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Yih-Ing Hser, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT01592461
First received: May 3, 2012
Last updated: May 4, 2012
Last verified: May 2012

May 3, 2012
May 4, 2012
September 2010
August 2015   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01592461 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
START Follow-up Study
START Follow-up Study (NIDA CTN Protocol 0050)

The purpose of the study is to conduct a follow-up of substance abuse patients (n=1,269) about 2 to 5 years since they were originally recruited from 8 substance abuse treatment clinics (located in 5 states) to participate in a prior clinical trial study called "START" (Starting Treatment with Agonist Replacement Therapies). The START Follow-up Study will be conducted over 5 years and will involve three follow-up interviews with START participants.

The specific aims of the START Follow-up Study are as follows.

  1. To determine longer-term outcomes of Suboxone versus methadone treatment received in the START
  2. To investigate patient and treatment factors associated with post-START treatment access, utilization, and outcomes among Suboxone and methadone patients
  3. To explore other correlates of the long-term outcomes among START patients.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Participants will include the 1,269 study participants from the original START Study (CTN-0027) that was conducted from 2006 to 2010 at eight community treatment programs (CTPs).

Opioid Dependence
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
1269
August 2015
August 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • To be eligible to participate in the study, individuals must have participated in CTN-0027 START.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01592461
CTN-0050, U10DA013045
No
Yih-Ing Hser, University of California, Los Angeles
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)
Principal Investigator: Yih-Ing Hser, Ph.D. University of California, Los Angeles
University of California, Los Angeles
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP